Pulmonary IgG4-related disease with favourable response to rituximab: A case report.
interstitial lung disease
rare lung diseases
Journal
Respirology case reports
ISSN: 2051-3380
Titre abrégé: Respirol Case Rep
Pays: United States
ID NLM: 101631052
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
12
07
2022
accepted:
11
10
2022
entrez:
4
11
2022
pubmed:
5
11
2022
medline:
5
11
2022
Statut:
epublish
Résumé
Pulmonary involvement of IgG4-associated disease is a rare condition with no codified treatment apart from steroid administration. We report here the case of a patient with pulmonary involvement of IgG4-RD successfully managed with Rituximab, in induction and maintenance therapy. This original case could support the use of Rituximab in rare situations of steroid-resistant or steroid-dependent pulmonary IgG4-RD.
Identifiants
pubmed: 36330374
doi: 10.1002/rcr2.1061
pii: RCR21061
pmc: PMC9623431
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e01061Informations de copyright
© 2022 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.
Déclaration de conflit d'intérêts
None declared.
Références
Respir Med. 2017 Nov;132:117-121
pubmed: 29229083
Ann Rheum Dis. 2015 Jun;74(6):1171-7
pubmed: 25667206
PLoS One. 2017 Sep 15;12(9):e0183844
pubmed: 28915275
Arthritis Rheumatol. 2020 Jan;72(1):7-19
pubmed: 31793250
Eur Respir Rev. 2021 Oct 5;30(162):
pubmed: 34615698